Core Insights - XR Immersive Technologies Inc. has appointed Shafin Diamond Tejani as Special Advisor and is focusing on completing financial filings, advancing health-related digital twin technology, and restructuring outstanding debt to strengthen its balance sheet [1][11]. Financial Filings - The company has completed all outstanding financial reporting requirements as of December 2, 2025, marking a significant step in its regulatory compliance [2]. - The completed filings include the 2024 audited annual financial statements, Q1 to Q3 2025 interim financial statements, and related Management Discussion & Analysis (MD&A) [4]. Health Technology Development - XR is advancing the commercialization of its digital twin, immersive simulation, and AI-driven health technologies, which include: - DigitalTwinX, a real-time digital model engine for patients and clinical workflows [3]. - An AI Avatar System for healthcare simulation that models patient behavior and supports remote education [3]. - Haptic and wearable sensor integration for rehabilitation and medical training [5]. - Continuous monitoring modules for chronic care, including glucose trend visualization and mobility tracking [5]. Strategic Initiatives - The company has been involved in a strategic review to explore applications of its technologies in sectors with long-term demand, particularly digital health [7]. - XR has engaged in exploratory discussions with various companies regarding potential pilot-scale development [8]. Next Steps - The immediate focus includes progressing through the British Columbia Securities Commission (BCSC) continuous disclosure review and addressing debt restructuring initiatives [10][11]. - The company aims to lift the Cease Trade Order (CTO) and prepare for the resumption of trading following the completion of the regulatory review [8].